Trials / Completed
CompletedNCT02045173
Automate Detection of Sleep Apnea by ApneascanTM
Screening for Sleep-disordered Breathing in Routine Cardiology Practice: Validation of the Apnea + Hypopnea Detection by an Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy-defibrillator (CRT-D) With Impedance-based Respiration Sensor (ApneaScanTM)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare, three months after implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator (CRT-D), the apnea-hypopnea index (AHI) obtained from conventional in-lab NPSG/NPG (AHIPSG) with similar indices obtained from autoscoring algorithms of the ApneaScan™, an implantable impedance-based respiration sensor (AHIAS).
Detailed description
This is a prospective, multi center, phase-IV with blinded analysis and central reading of polysomnography trial. The study is performed in patients with a standard CRT-D or Implantable Cardioverter Defibrillator (ICD) devices indication. A total of 160 subjects will be recruited in France. The study duration is 03 months for each subject.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Apneascan TM | Autoscoring algorithms with automatical detection of sleep apnea by the Apneascan TM |
| DEVICE | Polysomnography/polygraphy | 1 night polysomnography/polygraphy |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2014-01-24
- Last updated
- 2016-10-21
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02045173. Inclusion in this directory is not an endorsement.